Trademarkia Logo

Canada

C$
Trademark Search in Canada
MABIMMUNE

View On IC.GC.CA

MABIMMUNE
WITHDRAWN BY OWNER

on 24 Dec 2024

Last Applicant/ Owned by

Neurimmune Holding AG

Wagistrasse 138952 Schlieren

CH

Serial Number

2008266 filed on 27th Jan 2020

Correspondent Address

DENTONS CANADA LLP

99 BANK STREETSUITE 1420OTTAWA

ONTARIO

CA

K1P1H4

MABIMMUNE

Trademark usage description

pharmaceutical and veterinary preparations for the treatment of diseases of the nervous system, namely central nervous system infections, brain diseas Read More

Classification Information

Class [005]
Pharmaceutical and veterinary preparations for the treatment of diseases of the nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases, encephalitis, epilepsy, Alzheimer's, cerebral palsy, Parkinson's disease; pharmaceutical and veterinary preparations for the treatment of infectious diseases, namely neurological diseases namely Alzheimer's, Huntington's disease, cerebral palsy, Parkinson's disease; pharmaceutical and veterinary preparations for the treatment of infectious diseases, namely pharmaceutical preparations for the treatment of genito-urinary and pelvic diseases, disorders and infections, namely infertility, sexually transmitted diseases, incontinence and sexual dysfunction, pharmaceutical preparations for the treatment of genitourinary diseases, namely, urological diseases, infertility, sexually transmitted diseases, inflammatory pelvic diseases, pharmaceutical preparations for use in dermatology, namely dermatitis, skin pigmentation diseases, sexually transmitted diseases; pharmaceutical and veterinary preparations for the treatment of infectious diseases, namely inflammatory pelvic diseases, respiratory infections, eye infections, herpes, hepatitis, Acquired Immune Deficiency Syndrome (AIDS); pharmaceutical and veterinary preparations for the treatment of infectious diseases, namely pharmaceutical preparations for the treatment of metabolic diseases and disorders, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia, pharmaceutical preparations for the treatment of metabolic disorders, namely diabetes, bulimia nervosa, anorexia, obesity and hypothyroidism, pharmaceutical preparations for the treatment of diseases, disorders and infections of the endocrine system, namely growth and thyroid disorders; pharmaceutical and veterinary preparations for the treatment of autoimmune diseases of the immune system, namely immunologic deficiency syndromes, Acquired Immune Deficiency Syndrome (AIDS), asthma, ataxia telangiectasia, autoimmune polyglandular syndrome, burkitt lymphoma, immunodeficiency with hyper-IgM, leukemia chronic myeloid, neoplasms, severe combined immunodeficiency; pharmaceutical and veterinary preparations for the treatment of endocrine and metabolic diseases, namely diabetes, hypoglycaemia, gout, osteoarthritis, muscular dystrophy, anemia; pharmaceutical and veterinary preparations for the treatment of diseases of the circulatory system, namely leukemia, atherosclerosis, rheumatic fever, stroke, anemia, murmurs, heart attack, high blood pressure; pharmaceutical and veterinary preparations for the treatment of diseases of the eye namely disorders of eyelid, lacrimal system and orbit, disorders of conjunctiva, disorders of sclera, cornea, iris and ciliary body, disorders of choroid and retina, glaucoma, disorders of vitreous body and globe, disorders of optic nerve and visual pathways, disorders of ocular muscles, binocular movement, visual disturbances and blindness; diagnostic preparations for medical or veterinary use namely diagnostic preparations for clinical laboratory use, diagnostic preparations for medical laboratory use, diagnostic preparations for medical research use, diagnostic preparations for medical research use, diagnostic reagents for clinical laboratory use, diagnostic reagents for medical diagnostic use, diagnostic reagents for medical laboratory use, diagnostic reagents for medical research use; dietetic foods adapted for medical use namely dietetic sugar for medical use.

Classification kind code

11

Class [042]
Scientific and technological services and research and design relating thereto, namely research in the field of healing and biology, namely in the field of oncology, infectiology and metabolic disorders; drug research, namely in the field of oncology, infectiology and metabolic disorders; industrial analysis and research services in the field of oncology, infectious disease and metabolic disorders; design and development of computer hardware and software.

Classification kind code

11

Class [044]
Medical services, namely providing diagnostic services in the field of cancer, infectious disease, and metabolic disorders and veterinary services; services in the field of healing, namely diagnostic services in the field of healing, namely in the field of oncology, infectiology and metabolic disorders.

Classification kind code

11

Mark Details

Serial Number

2008266

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 5
on 24th Dec 2024		Withdrawn by Owner
Submitted for opposition 22
on 22nd Jul 2024		Search Recorded
Submitted for opposition 20
on 22nd Jul 2024		Examiner's First Report
Submitted for opposition 287
on 7th Jun 2022		Pre-Assessment Letter Sent
Submitted for opposition 31
on 12th Feb 2020		Formalized
Submitted for opposition 1
on 28th Jan 2020		Created
Submitted for opposition 30
on 27th Jan 2020		Filed